Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.

× No keyword cloud information.

7 in total

1. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

Authors: J Falloon; J Lavelle; D Ogata-Arakaki; A Byrne; A Graziani; A Morgan; M A Amantea; K Ownby; M Polis; R T Davey
Journal: Antimicrob Agents Chemother Date: 1994-07 Impact factor: 5.191

2. Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.

Authors: G Gatti; M Merighi; J Hossein; S Travaini; R Casazza; M Karlsson; M Cruciani; D Bassetti
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

Review 3. Human antiprotozoal therapy: past, present, and future.

Authors: M Khaw; C B Panosian
Journal: Clin Microbiol Rev Date: 1995-07 Impact factor: 26.132

4. Risk factors for severe disease due to Toxoplasma gondii in HIV-positive patients.

Authors: H J Stellbrink; R Führer-Burow; A Raedler; H Albrecht; S Fenske
Journal: Eur J Epidemiol Date: 1993-11 Impact factor: 8.082

5. Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.

Authors: G Gatti; A Loy; R Casazza; F Miletich; M Cruciani; D Bassetti
Journal: Antimicrob Agents Chemother Date: 1995-05 Impact factor: 5.191

6. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.

Authors: E M Carlin; R J Coker; R D Goldin; J R Harris
Journal: Genitourin Med Date: 1993-04

Review 7. Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients.

Authors: D Smith; B Gazzard
Journal: Drugs Date: 1991-10 Impact factor: 9.546

7 in total